BioHiTech Global Cash Flow - Quarterly (NASDAQ:BHTG)

Add to My Stocks
$3.48 $0.1 (2.96%) BHTG stock closing price Jul 20, 2018 (Closing)

The BioHiTech Global cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. While its important to look at the BioHiTech Global debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as BioHiTech Global revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. BioHiTech Global stock analysis shows negative net income cash flow of $-5.22M till 2018 Q1. This statement is important because profits alone cannot pay employees, or bills. Cash is required. BHTG decrease in investments stood at a value of $-0.09M for the latest quarter 2018 Q1.

View and download details of BioHiTech Global cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-0.61M1.11M------0.26M-0.18M1.43M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net3.71M2.05M1.57M--1.01M----
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment------0.01M----0.01M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments--1.03M-1.03M-1.03M-1.03M-----
Other Cash Inflow (Outflow) from Investment Activities-0.09M-1.04M-0.13M-0.07M-0.03M-----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares1.12M2.27M--------
Issuance (Repayment) of Debt Securities5.99M5.15M5.16M3.07M1.99M5.64M3.92M3.3M1.77M3.08M
Increase (Decrease) in Bank & Other Borrowings-2.46M-----0.02M-0.02M-0.02M-0.02M-
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.23M-0.02M-0.02M-0.01M-0.01M-0.19M-0.16M-0.13M-0.08M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------0.01M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year----------
Cash & Equivalents at Year End3.22M---------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While BioHiTech Global stock price history provides the price history of a stock, BioHiTech Global stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • BioHiTech Global has cash of $3.22M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the BioHiTech Global stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. BioHiTech Global lost $-2M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.09M for BHTG stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. BioHiTech Global earned $4.42M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For BioHiTech Global Cash Flow